1-7 of 7
Roy Chemaly
Close
Sort by
Journal Articles

Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center

Fareed Khawaja, Rishab Prakash, Joseph Sassine, Guy Handley, Tracy VanWieren, Georgios Angelidakis, Swaminathan P. Iyer, Jeremy L. Ramdial, Sairah Ahmed, Yago Nieto, Amy Spallone, Ella J. Ariza-Heredia, Roy Chemaly
Journal: Blood
Blood (2022) 140 (Supplement 1): 7533–7535.
https://doi.org/10.1182/blood-2022-167908
Published: 2022
Journal Articles

Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections

Jeremy L. Ramdial, Rima M. Saliba, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Elizabeth J. Shpall, Roy Chemaly, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2855.
https://doi.org/10.1182/blood-2021-153997
Published: 2021
Journal Articles

The Incidence and Impact of Clostridioides Difficile Infection (CDI) on Outcomes after Allogeneic Hematopoietic Cell Transplant (alloHCT) - a CIBMTR Study

Muthalagu Ramanathan, Bipin B. Savani, Naya He, Soyoung Kim, Min Chen, Roy Chemaly, Christopher E Dandoy, Miguel-Angel Perales, Marcie L. Riches, Celalettin Ustun
Journal: Blood
Blood (2021) 138 (Supplement 1): 2894.
https://doi.org/10.1182/blood-2021-145774
Published: 2021
Journal Articles

Freesia Study Design: JNJ-53718678 in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Roy Chemaly, MD PhD, Michael Boeckh, MD, Karin Weber, Roman Fleischhackl, Marita Stevens, Bart Michiels, David Rivas, Jason Chien, James Witek
Journal: Blood
Blood (2019) 134 (Supplement_1): 4478.
https://doi.org/10.1182/blood-2019-130423
Published: 2019
Journal Articles

Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Amanda L. Olson, MD, Ruitao Lin, Mustafa Bdaiwi, MD, Peter F Thall, Hind Rafei, MD, Indreshpal Kaur, PhD, Li Li, MD, Glorette Abueg, Melissa Timmons, Roy Chemaly, MD PhD, David Marin, MD, Amin M. Alousi, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Roy B Jones, MD PhD, Borje S Andersson, MD PhD, Betul Oran, MDMS, Ala Abuddayeh, Uday Popat, MD, Richard E. Champlin, MD, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3596.
https://doi.org/10.1182/blood-2019-126028
Published: 2019
Journal Articles

Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial

Amanda L. Olson, MD, Muharrem Muftuoglu, MD, Indreshpal Kaur, PhD, Li Li, MD, Glorette Abueg, Roy Chemaly, MD PhD, Eric Yvon, PhD, Peter F Thall, PhD, David Marin, MD, Amin M. Alousi, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Roy Jones, MD PhD, Borje S Andersson, MD PhD, Nina Shah, MD, Betul Oran, MD, Ala Abudayyeh, Uday R. Popat, MD, Richard E. Champlin, MD, Elizabeth J Shpall, MD, Katy Rezvani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 504.
https://doi.org/10.1182/blood.V128.22.504.504
Published: 2016
Journal Articles

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Drew Winston, Jo-Anne van Burik, Vinod Pullarkat, Genovefa Papanicolaou, Ravi Vij, Estil Vance, George Alangaden, Roy Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Carolyn Dougherty, Stephen Villano, Michael Boeckh
Journal: Blood
Blood (2006) 108 (11): 593.
https://doi.org/10.1182/blood.V108.11.593.593
Published: 2006